Tag Archives: AGEN

Top 10 High Tech Stocks For 2019

Cash is king in times of stress.

That’s how Daiwa SB Investments Ltd.’s Takeshi Yokouchi is playing the recent rout that has seen emerging-market assets erase their 2018 gains — selling positions and raising liquidity.

He’s reducing his overall allocation to emerging markets, offloading bonds and currencies from Turkey and Indonesia, the Tokyo-based senior fund manager said in an interview. Yokouchi, who runs a fund that invests in high-yielding securities, is also increasing his dollar holdings amid the prospect of further rate hikes by the Federal Reserve.

#lazy-img-327837654:before{padding-top:56.25%;}

“I am becoming increasingly cautious on emerging markets because they have been under selling pressure due to their external vulnerability amid weakening risk sentiment,” said Yokouchi at Daiwa SB, which oversaw 6 trillion yen ($54 billion) as of the end of March. “I view this as a temporary correction, but we don’t see the light at the end of the tunnel just yet so this weak environment is likely to continue for a while.”

Top 10 High Tech Stocks For 2019: Tiffany & Co.(TIF)

Advisors’ Opinion:

  • [By ]

    HSBC’s top stocks list is mostly dominated by large-cap plays that happen to pay attractive dividend yields. More importantly, the stocks already have a decent amount of momentum behind them: the average one-month performance is +5.5%. 

    Baker Hughes (BHGE) Tiffany & Co. (TIF) The Mosaic Company (MOS) Deutsche Telekom Schneider Electric Adidas (ADDYY) Unicredit  CRH (CRH) Luftansa  GlaxosmithKline (GSK) Associated British Foods   Fresnillo China Construction Bank China Overseas Land & Inv. Geely Automobile Holdings CRCC China Resources Beer Samsung Electronic Sasol Adani Ports and SEZ

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Lowe's Companies, Inc. (NYSE: LOW) to report quarterly earnings at $1.25 per share on revenue of $17.63 billion before the opening bell. Lowe's shares declined 0.35 percent to $85.45 in pre-market trading.
    Analysts expect NetApp, Inc. (NASDAQ: NTAP) to post quarterly earnings at $1.01 per share on revenue of $1.60 billion after the closing bell. NetApp shares dropped 2.09 percent to close at $67.02 on Tuesday.
    Urban Outfitters, Inc. (NASDAQ: URBN) reported better-than-expected earnings for its fiscal first quarter on Tuesday. Urban Outfitters shares dropped 2.21 percent to $40.30 in the pre-market trading session.
    Before the markets open, Tiffany & Co. (NYSE: TIF) is projected to report quarterly earnings at $0.83 per share on revenue of $957.49 million. Tiffany shares gained 0.45 percent to $102.70 in pre-market trading.
    Analysts are expecting Target Corporation (NYSE: TGT) to have earned $1.38 per share on revenue of $16.50 billion in the latest quarter. Target will release earnings before the markets open. Target shares rose 0.07 percent to $75.52 in pre-market trading.
    Hewlett Packard Enterprise Co (NYSE: HPE) reported stronger-than-expected profit for its fiscal second quarter and raised its FY18 GAAP earnings outlook. Hewlett Packard Enterprise shares rose 0.40 percent to $17.48 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Chris Lange]

    Tiffany & Co. (NYSE: TIF) released its fiscal first-quarter financial results before the markets opened on Wednesday. The company posted $1.14 in earnings per share (EPS) on $1.03 billion in revenue, compared with consensus estimates from Thomson Reuters that called for $0.83 in EPS on revenue of $958.17 million. In the same period of last year, the luxury retailer said it had EPS of $0.74 and $899.6 million in revenue.

Top 10 High Tech Stocks For 2019: NanoString Technologies, Inc.(NSTG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NanoString Technologies (NASDAQ: NSTG) is one of 91 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare NanoString Technologies to related businesses based on the strength of its earnings, profitability, institutional ownership, dividends, risk, valuation and analyst recommendations.

  • [By Max Byerly]

    Cellular Biomedicine Group (NASDAQ: NSTG) and NanoString Technologies (NASDAQ:NSTG) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NanoString Technologies (NSTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on NanoString Technologies (NSTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks For 2019: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

  • [By Cory Renauer]

    These three start-ups have gotten close more than once, but they still don’t have any products to sell. What they have created, though, is a trail of disappointed investors who have watched at least $1 billion go up in flames.

    Company (Symbol) Market Capitalization Year of Incorporation Accumulated Deficit, Sept. 30, 2018 Focus
    Novavax (NASDAQ:NVAX) $269 million 1987 $1.25 billion Vaccines
    Geron (NASDAQ:GERN) $285 million 1990 $1.00 billion Oncology
    Agenus (NASDAQ:AGEN) $405 million 1994 $1.13 billion Vaccines/oncology

    Data source: company SEC filings.

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech. Agenus Inc. (NASDAQ:AGEN) and Regeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.  

  • [By George Budwell]

    Agenus (NASDAQ:AGEN), a small-cap cancer immunotherapy and vaccine company, has started to claw its way back from a steep downturn that began last April. Specifically, the drugmaker’s shares have spiked by a healthy 29% over just the past three trading sessions. 

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:

    Get Agenus alerts:

    Agenus Inc. (AGEN): Stock Have a Latest Story: (bitcoinpriceupdate.review) P/E and PEG Value Under Consideration – Agenus Inc. (NASDAQ:AGEN) (nasdaqjournal.com) Sizzling Spotlight- Kohl’s Corporation (NYSE:KSS), Agenus Inc. (NASDAQ:AGEN), The Hartford Financial Services … (journalfinance.net) Checking on Key Pivot Levels for Agenus Inc. (NASDAQ:AGEN): Woodie Pivot at 3.175 (stocknewscaller.com) Watch List Stock— Agenus Inc. (AGEN) (stockmarketstop.com)

    Shares of AGEN traded down $0.10 during trading hours on Friday, reaching $2.70. 6,890,759 shares of the company traded hands, compared to its average volume of 1,149,867. The firm has a market capitalization of $280.80 million, a P/E ratio of -2.20 and a beta of 1.70. Agenus has a 12-month low of $2.70 and a 12-month high of $6.19. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of -0.11.

Top 10 High Tech Stocks For 2019: HSBC Holdings plc(HSBC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Flagstar Bancorp (NYSE: HSBC) and HSBC (NYSE:HSBC) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

  • [By Max Byerly]

    HSBC (NYSE: HSBC) and Kearny Financial (NASDAQ:KRNY) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

  • [By Steve Symington]

    As for individual stocks, fresh earnings reports left Walmart (NYSE:WMT) and HSBC Holdings (NYSE:HSBC) moving in opposite directions today.

    Image source: Getty Images.

  • [By ]

    HSBC Holdings PLC (NYSE: HSBC)
    In order to grow, economies need capital. HSBC has it. With $2.52 trillion in total assets, HSBC holds the spot as the world’s seventh largest bank by total assets and is currently ranked as Europe’s largest bank. Covering the full gamut of financial services, from banking to wealth management to capital markets, HSBC’s international and emerging market focus make the bank the company to own going forward. Also, normalizing interest rates should benefit the company’s bottom line.

  • [By Stephan Byrd]

    HSBC (NYSE:HSBC) was upgraded by stock analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Tuesday, The Fly reports.

Top 10 High Tech Stocks For 2019: ThyssenKrupp AG (TYEKF)

Advisors’ Opinion:

  • [By ]

    United Technologies’ Otis division manufactures and services elevators, escalators, and other people moving devices. The business is reasonably attractive since there is a fair degree of concentration. Four major companies, Kone Oyj (OTCPK:KNYJF) (OTCPK:KNYJY), ThyssenKrupp (OTCPK:TYEKF) (OTCPK:TKAMY), Schindler (OTCPK:SHLAF) (OTC:SHNDY), and Otis, account for over 50% market share. The main long-term drivers of the industry are urbanization. As you might guess, elevator demand is strongest in dense urban environments where almost every building is multi-story.

Top 10 High Tech Stocks For 2019: iShares S&P Global Clean Energy Index Fund(ICLN)

Advisors’ Opinion:

  • [By Scott Levine]

    For those afraid of getting burned with the solar ETF, the iShares Global Clean Energy ETF (NASDAQ:ICLN) may be a more attractive option since the fund’s stated objective is to “track the investment results of the S&P Global Clean Energy Index.” The fund’s 30 holdings represent global leaders in renewable energy, ranging from solar power to geothermal to waste-to-energy. Like the Invesco Solar ETF, the iShares Global Clean Energy ETF is not actively managed and carries a fairly low expense ratio of 0.47%. Distributions are made semiannually and currently offer a trailing-12-month yield of 2.34%.

Top 10 High Tech Stocks For 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

  • [By Ethan Ryder]

    Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 10 High Tech Stocks For 2019: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Great West Life Assurance Co. Can decreased its position in PDC Energy Inc (NASDAQ:PDCE) by 2.0% in the 2nd quarter, HoldingsChannel reports. The fund owned 83,880 shares of the energy producer’s stock after selling 1,700 shares during the period. Great West Life Assurance Co. Can’s holdings in PDC Energy were worth $5,071,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    An issue of PDC Energy Inc (NASDAQ:PDCE) debt fell 1% against its face value during trading on Friday. The debt issue has a 6.125% coupon and is set to mature on September 15, 2024. The debt is now trading at $97.50 and was trading at $99.63 one week ago. Price moves in a company’s debt in credit markets sometimes anticipate parallel moves in its share price.

  • [By Shane Hupp]

    PDC Energy Inc (NASDAQ:PDCE) – Equities researchers at Seaport Global Securities cut their Q2 2019 earnings estimates for PDC Energy in a research note issued to investors on Wednesday, February 27th. Seaport Global Securities analyst M. Kelly now expects that the energy producer will post earnings of $0.40 per share for the quarter, down from their prior estimate of $0.46. Seaport Global Securities also issued estimates for PDC Energy’s Q3 2019 earnings at $0.49 EPS, Q4 2019 earnings at $0.57 EPS, FY2019 earnings at $2.07 EPS, Q1 2020 earnings at $0.77 EPS, Q2 2020 earnings at $0.66 EPS, Q3 2020 earnings at $0.74 EPS, Q4 2020 earnings at $0.83 EPS and FY2020 earnings at $3.00 EPS.

Top 10 High Tech Stocks For 2019: Blackrock MuniYield Fund, Inc.(MYD)

Advisors’ Opinion:

  • [By Max Byerly]

    Blackrock Muniyield Fund Inc. (NYSE:MYD) announced a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Stockholders of record on Friday, September 14th will be given a dividend of 0.061 per share by the financial services provider on Monday, October 1st. This represents a $0.73 dividend on an annualized basis and a dividend yield of 5.30%. The ex-dividend date of this dividend is Thursday, September 13th.

Top 10 High Tech Stocks For 2019: MBIA, Inc.(MBI)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market finished lower on Friday, with triple-digit losses for the Dow Jones Industrial Average and modest declines of as much as half a percent for other major benchmarks. A mix of economic and political news kept investors on their toes to end the week, as fears of a possible attack on Syria watered down some of the potential upside that could have stemmed from solid earnings results from the banking sector during the morning. Even though many investors have pretty positive expectations going into earnings season, some companies suffered from disappointing news that sent their shares lower. Arista Networks (NYSE:ANET), Dropbox (NASDAQ:DBX), and MBIA (NYSE:MBI) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Stephan Byrd]

    Monster Byte (CURRENCY:MBI) traded flat against the US dollar during the 24 hour period ending at 18:00 PM Eastern on February 20th. Over the last seven days, Monster Byte has traded 99.4% higher against the US dollar. One Monster Byte token can now be bought for $0.0277 or 0.00000704 BTC on major cryptocurrency exchanges. Monster Byte has a total market capitalization of $465,423.00 and approximately $0.00 worth of Monster Byte was traded on exchanges in the last day.

  • [By Joseph Griffin]

    Monster Byte (CURRENCY:MBI) traded flat against the US dollar during the 1-day period ending at 12:00 PM E.T. on October 5th. Monster Byte has a market cap of $888,357.00 and approximately $0.00 worth of Monster Byte was traded on exchanges in the last day. During the last week, Monster Byte has traded up 49.2% against the US dollar. One Monster Byte token can currently be purchased for about $0.0528 or 0.00000800 BTC on major exchanges.

  • [By Motley Fool Transcribers]

    MBIA Inc  (NYSE:MBI)Q4 2018 Earnings Conference CallMarch 01, 2019, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    MBIA Inc. (NYSE:MBI) saw unusually large options trading on Tuesday. Stock investors purchased 13,349 call options on the company. This represents an increase of 1,714% compared to the average daily volume of 736 call options.

Top Blue Chip Stocks To Invest In 2019

Wall Street veteran Sam Stovall is warning stock investors the longest bull market on record will end with an epic meltdown.

According to the CFRA chief investment strategist, it’s a side effect of an unprecedented business cycle.

“Three conditions: Very long, very high, very expensive,” Stovall said Tuesday on CNBC’s “Futures Now.” “History would imply that be careful because now we’re likely to fall into a very deep bear market when it does finally hit with the average decline being close to 40 percent plus.”

His latest thoughts came as the Dow was hitting record highs. The blue chip index is now up more than 8 percent this year. The S&P 500 is performing a tad better — up more than 9 percent for 2018.

Since the bull market began on March 9, 2009, the Dow and S&P 500 have soared more than 300 percent each. For now, Stovall doesn’t see any near-term signs that the win streak is about to end.

Top Blue Chip Stocks To Invest In 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA’s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

Top Blue Chip Stocks To Invest In 2019: ENERGY TRANSFER PARTNERS(ETP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Metaverse ETP (CURRENCY:ETP) traded down 6.4% against the U.S. dollar during the twenty-four hour period ending at 21:00 PM E.T. on May 27th. Metaverse ETP has a total market cap of $30.72 million and $4.17 million worth of Metaverse ETP was traded on exchanges in the last 24 hours. During the last week, Metaverse ETP has traded down 6.4% against the U.S. dollar. One Metaverse ETP coin can now be purchased for about $0.86 or 0.00011713 BTC on popular exchanges including TDAX, HitBTC, TOPBTC and Bitfinex.

  • [By Matthew DiLallo]

    After lots of analysis and discussion, Energy Transfer Equity recently announced that it has agreed to merge with its MLP Energy Transfer Partners (NYSE:ETP) in a $27 billion deal that will create a nearly $100 billion energy infrastructure behemoth. In addition to increasing the size and scale of the company, several other reasons were highlighted by CFO Tom Long about why the company is happy to finally be able to announce this transaction: 

  • [By Matthew DiLallo]

    When a dividend yield gets over 10%, it’s usually a sign that the market believes a cut is coming down the pipeline. Given that Energy Transfer Partners (NYSE:ETP) and Summit Midstream Partners (NYSE:SMLP) currently yield 11.6% and 14.5%, respectively, the market seems to believe that will be the case for both of those master limited partnerships. That’s why investors should steer clear of those two high-yielding stocks and instead consider Crestwood Equity Partners’ (NYSE:CEQP) much safer 7% payout.

Top Blue Chip Stocks To Invest In 2019: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By George Budwell]

    The small-cap immuno-oncology company Agenus (NASDAQ:AGEN) and the inhaled insulin company MannKind Corporation (NASDAQ:MNKD) are prime examples of this phenomenon. Even though both of these companies have been in existence for over two decades, these two particular biotechs have failed to bring a product to market capable of generating a significant revenue stream. As a result, these two companies have essentially been forced to wipe out their early shareholders through serial dilution.

  • [By George Budwell]

    Agenus (NASDAQ:AGEN), a small-cap cancer immunotherapy and vaccine company, has started to claw its way back from a steep downturn that began last April. Specifically, the drugmaker’s shares have spiked by a healthy 29% over just the past three trading sessions. 

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

Top 10 Medical Stocks To Buy Right Now

Like it or not, by the time you turn 30, you’re basically a full-fledged adult, and with that comes certain financial responsibilities you’ll need to get a handle on. Here are three money-related goals you should aim to achieve by age 30.

1. Have a fully loaded emergency fund

Life has a way of surprising us, both for better and for worse. But sometimes, those unpleasant surprises come in the form of automobile breakdowns, busted appliances at home, or medical bills that catch us off guard. And let’s not forget the possibility of getting laid off at work — something that can happen to even the most diligent employees among us.

IMAGE SOURCE: GETTY IMAGES.

That’s why it’s crucial to have a healthy emergency fund. While you might struggle to sock away that money when you’re younger, by the time you turn 30, that account should be nice and robust. At a minimum, your emergency fund should contain enough cash to cover three months’ worth of living expenses, but for better protection, aim for six months’ worth. This means that if you typically spend $3,000 a month on bills, your goal should be to have $18,000 in savings.

Top 10 Medical Stocks To Buy Right Now: Ecolab Inc.(ECL)

Advisors’ Opinion:

  • [By ]

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

    PTC (PTC) : “Not my cup of tea but I understand it’s in the sweet spot of tech.”

  • [By Logan Wallace]

    Investors bought shares of Ecolab Inc. (NYSE:ECL) on weakness during trading on Tuesday. $37.89 million flowed into the stock on the tick-up and $13.41 million flowed out of the stock on the tick-down, for a money net flow of $24.48 million into the stock. Of all stocks tracked, Ecolab had the 33rd highest net in-flow for the day. Ecolab traded down ($0.18) for the day and closed at $157.22

  • [By Neha Chamaria]

    Using the above method, I believe the following five stocks are some of the best Dividend Aristocrats to consider today.

    Dividend Aristocrat Payout Ratio (Last 12 Months) 5-Year Dividend CAGR*  10-Year Dividend CAGR*
    Ecolab (NYSE:ECL) 30.2% 12.9% 12.3%
    W.W. Grainger (NYSE:GWW) 45.7% 10.6% 14.2%
    Cintas Corporation (NASDAQ:CTAS) 23.7% 19.8% 13.1%
    Roper Technologies (NYSE:ROP) 14.6% 20.4% 18.5%
    A. O. Smith (NYSE:AOS) 33.6% 25.5% (2.2%)

    *Compound annual growth rate. Data source: S&P Global Market Intelligence. Table by author.

  • [By Joseph Griffin]

    Ecolab Inc. (NYSE:ECL) has received a consensus rating of “Hold” from the twenty brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, ten have given a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price objective among brokers that have covered the stock in the last year is $146.00.

Top 10 Medical Stocks To Buy Right Now: Macy's Inc(M)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Macy’s (NYSE:M) wrapped up its 2018 fiscal year last week. The iconic department store giant won’t report its full results until later this month, but it already reduced its full-year earnings per share guidance to a range of $3.95 to $4.00 in an early January investor update. (On the bright side, that’s still higher than Macy’s initial EPS forecast for fiscal 2018.)

  • [By Rich Duprey]

    The retailer puts part of the blame on the weather, but the cooler temps didn’t seem to effect Macy’s (NYSE: M), which reported truly robust results that had many expecting J.C. Penney would follow suit. Although Macy’s did say a few markets were impacted, they were offset by others that were not. That weather should drag down Penney when it has more stores than its rival — which should have spread out the impact more — indicates it is more of an excuse than a reason.

  • [By Chris Johnson]

    Although several big names have already had their turn in the earnings confessional – including Walmart Inc. (NYSE: WMT), Macy’s Inc. (NYSE: M), and Home Depot Inc. (NYSE: HD) – this week has a respectable lineup with the likes of Kohl’s Corp. (NYSE: KSS), Lowe’s Companies Inc. (NYSE: LOW), and Target Corp. (NYSE: TGT).

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Macy's, Inc. (NYSE: M) to report quarterly earnings at $0.35 per share on revenue of $5.39 billion before the opening bell. Macy's shares fell 0.47 percent to $29.79 in after-hours trading.
    Analysts are expecting Cisco Systems, Inc. (NASDAQ: CSCO) to have earned $0.65 per share on revenue of $12.43 billion in the latest quarter. Cisco will release earnings after the markets close. Cisco shares declined 0.07 percent to $45.45 in after-hours trading.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Boot Barn shares climbed 9.97 percent to $24.15 in the after-hours trading session.
    After the markets close, Flowers Foods, Inc. (NYSE: FLO) is projected to post quarterly earnings at $0.31 per share on revenue of $1.20 billion. Flowers Foods shares dropped 0.37 percent to $21.70 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Daniel B. Kline]

    To compete, traditional chains have had to become destinations — experiences that provide customers with good reason to leave the house. That has been a particularly challenging task for department stores, and Macy’s (NYSE:M) has not been immune to the troubles that have plagued its peers.

  • [By Jim Crumly]

    As for individual stocks, Constellation Brands (NYSE:STZ) announced a big investment in cannabis producer Canopy Growth (NYSE:CGC), and Macy’s (NYSE:M) reported second-quarter results.

Top 10 Medical Stocks To Buy Right Now: FuelCell Energy Inc.(FCEL)

Advisors’ Opinion:

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 4% in short interest during the period. Some 7.42 million shares were short as of June 15. The stock closed at $1.37 on Tuesday, down about 1.4% for the day, in a 52-week range of $1.18 to $2.49. Shares traded down more than 10% in the short interest period, and days to cover dropped from 17 to six.

  • [By Logan Wallace]

    FuelCell Energy (NASDAQ: FCEL) and HRG Group (NYSE:HRG) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on FuelCell Energy (FCEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 43.9% in short interest during the period. Some 10.68 million shares were short as of June 29. The stock closed most recently at $1.33, down about 1.5% for the day, in a 52-week range of $1.29 to $2.49. Shares traded down more than 20% in the short interest period, and days to cover dropped from six to four.

Top 10 Medical Stocks To Buy Right Now: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Agenus (NASDAQ:AGEN) was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Monday.

  • [By George Budwell]

    Shares of the small-cap biotech Agenus (NASDAQ:AGEN) reversed its year-long down trend by gaining a stately 20.1% last month, according to data from S&P Global Market Intelligence. What sparked this marked turnaround?

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

Top 10 Medical Stocks To Buy Right Now: Northern Trust Corporation(NTRS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Russell Investments Group Ltd. reduced its stake in shares of Northern Trust Co. (NASDAQ:NTRS) by 11.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 242,179 shares of the asset manager’s stock after selling 31,938 shares during the quarter. Russell Investments Group Ltd. owned 0.11% of Northern Trust worth $24,953,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s analysis:

    Get Northern Trust alerts:

    Northern Trust Co. (NTRS) Receives Consensus Rating of “Hold” from Analysts (americanbankingnews.com) $1.50 Billion in Sales Expected for Northern Trust Co. (NTRS) This Quarter (americanbankingnews.com) Ex-Dividend Reminder: United Bankshares, CME Group and Northern Trust Corp (nasdaq.com) Zacks: Analysts Expect Northern Trust Co. (NTRS) to Post $1.62 Earnings Per Share (americanbankingnews.com) Stocks With Rising Relative Strength: Northern Trust (investors.com)

    Northern Trust opened at $106.92 on Friday, according to MarketBeat.com. The company has a quick ratio of 0.66, a current ratio of 0.66 and a debt-to-equity ratio of 0.34. The company has a market cap of $24.02 billion, a price-to-earnings ratio of 22.14, a price-to-earnings-growth ratio of 1.41 and a beta of 0.92. Northern Trust has a 12-month low of $85.69 and a 12-month high of $110.81.

  • [By Max Byerly]

    Press coverage about Northern Trust (NASDAQ:NTRS) has trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Northern Trust earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news articles about the asset manager an impact score of 46.6478323403648 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top 10 Medical Stocks To Buy Right Now: RELX N.V.(RENX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Relx (NYSE:RENX) was upgraded by research analysts at Barclays to a “buy” rating in a report released on Monday.

    RENX has been the subject of several other research reports. Zacks Investment Research raised shares of Relx from a “sell” rating to a “hold” rating in a report on Thursday, August 16th. UBS Group cut shares of Relx from a “neutral” rating to a “sell” rating in a research note on Thursday, June 14th. Two investment analysts have rated the stock with a sell rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $23.00.

Top 10 Medical Stocks To Buy Right Now: Concho Resources Inc.(CXO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CargoX (CURRENCY:CXO) traded 0.4% lower against the U.S. dollar during the 1-day period ending at 23:00 PM ET on August 18th. CargoX has a total market cap of $2.98 million and $23,802.00 worth of CargoX was traded on exchanges in the last 24 hours. In the last seven days, CargoX has traded 0.1% higher against the U.S. dollar. One CargoX token can currently be purchased for about $0.0231 or 0.00000365 BTC on exchanges including IDEX and Kucoin.

  • [By Joseph Griffin]

    Laurion Capital Management LP acquired a new stake in shares of Concho Resources Inc (NYSE:CXO) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 10,260 shares of the oil and natural gas company’s stock, valued at approximately $1,419,000.

  • [By Ethan Ryder]

    Tredje AP fonden grew its stake in Concho Resources (NYSE:CXO) by 4.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,417 shares of the oil and natural gas company’s stock after acquiring an additional 560 shares during the quarter. Tredje AP fonden’s holdings in Concho Resources were worth $2,017,000 at the end of the most recent quarter.

  • [By Lee Jackson]

    Earlier this year, this company bought RSP Permian for $9.5 billion, and most on Wall Street like the deal. Concho Resources Inc. (NYSE: CXO) is an independent oil and natural gas company engaged in the acquisition, development and exploration of oil and natural gas properties.

  • [By Max Byerly]

    Concho Resources Inc (NYSE:CXO) has been assigned an average recommendation of “Buy” from the twenty-seven research firms that are presently covering the stock, MarketBeat Ratings reports. Ten research analysts have rated the stock with a hold recommendation and sixteen have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $177.50.

Top 10 Medical Stocks To Buy Right Now: CRA InternationalInc.(CRAI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the news articles that may have impacted Accern Sentiment Analysis’s rankings:

    Get CRA International alerts:

    CRA International (CRAI) Q2 Earnings Beat, Revenue View Up (zacks.com) Brokerages Anticipate CRA International, Inc. (CRAI) to Post $0.52 Earnings Per Share (americanbankingnews.com) Q3 2019 EPS Estimates for CRA International, Inc. (CRAI) Boosted by William Blair (americanbankingnews.com) CRA International, Inc. (CRAI) CEO Paul Maleh on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com)

    Shares of CRAI traded down $0.04 during midday trading on Friday, hitting $55.55. The stock had a trading volume of 39,451 shares, compared to its average volume of 37,310. CRA International has a 1 year low of $34.49 and a 1 year high of $58.74. The company has a market cap of $447.94 million, a P/E ratio of 29.08 and a beta of 0.80.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CRA International (CRAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    CRA International, Inc. (NASDAQ:CRAI) Director William F. Concannon sold 9,500 shares of CRA International stock in a transaction dated Wednesday, May 30th. The stock was sold at an average price of $55.37, for a total value of $526,015.00. Following the sale, the director now directly owns 28,491 shares of the company’s stock, valued at $1,577,546.67. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

  • [By Joseph Griffin]

    BidaskClub downgraded shares of CRA International (NASDAQ:CRAI) from a strong-buy rating to a buy rating in a research note issued to investors on Saturday morning.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on CRA International (CRAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on CRA International (CRAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy Right Now: Nicholas Financial Inc.(NICK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Nicholas Financial (NASDAQ: NICK) and CPI Card Group (NASDAQ:PMTS) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

  • [By Logan Wallace]

    Nicholas Financial (NASDAQ: NICK) and Encore Capital Group (NASDAQ:ECPG) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk.

  • [By Ethan Ryder]

    Nicholas Financial (NASDAQ: NICK) and Encore Capital Group (NASDAQ:ECPG) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

  • [By Max Byerly]

    Nicholas Financial, Inc. (NASDAQ:NICK) major shareholder Adam K. Peterson acquired 5,500 shares of the company’s stock in a transaction that occurred on Thursday, August 9th. The shares were acquired at an average cost of $10.80 per share, for a total transaction of $59,400.00. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Top 10 Medical Stocks To Buy Right Now: Terex Corporation(TEX)

Advisors’ Opinion:

  • [By Rich Smith]

    Shares of Terex Corporation (NYSE:TEX) closed 10.1% lower on Wednesday, even as the construction equipment maker reported Q2 earnings that met or exceeded Wall Street’s expectations.

  • [By Rich Smith]

    All year long, Terex (NYSE:TEX) stock has been pacing the S&P 500’s performance — and even leading it a bit, up 15% to the market’s 14% gain. Today, shares are moving in and out of negative territory.

  • [By Stephan Byrd]

    Asset Management One Co. Ltd. acquired a new stake in Terex Co. (NYSE:TEX) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 9,770 shares of the industrial products company’s stock, valued at approximately $365,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Terex (TEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Terex (TEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Terex (TEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks For 2019

April 7, 2017: Markets opened nearly flat Friday and did not gather any positive strength until mid-day. Telecom and consumer staples were the top performing sectors while the utilities and energy sectors lagged. WTI crude oil for May delivery settled at $52.24 a barrel, up 1% on the day and at its highest level since March 7. June gold added 0.3% on the day to settle at $1,257.30. Equities were headed for a mixed close shortly before the bell as the DJIA traded up 0.01% for the day, the S&P 500 traded down 0.04%, and the Nasdaq Composite traded up 0.03%.

Stocks traded very near the break-even line just minutes before the closing bell. The closing tally could finish with either a small gain or a small loss for any or all of the indexes.

The DJIA stock posting the largest daily percentage gain ahead of the close Friday was Wal-Mart Stores Inc. (NYSE: WMT) which traded up 2.10% at $72.93. The stock’s 52-week range is $62.72 to $75.19. Volume was about 10% below the daily average of around 9.2 million shares. The company’s stock was upgraded to Outperform this morning at Telsey.

Top 10 Performing Stocks For 2019: Piedmont Office Realty Trust, Inc.(PDM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Sumitomo Mitsui Trust Holdings Inc. reduced its holdings in shares of Piedmont Office Realty Trust (NYSE:PDM) by 2.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 131,748 shares of the real estate investment trust’s stock after selling 3,194 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.10% of Piedmont Office Realty Trust worth $2,317,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Piedmont Office Realty Trust (PDM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Swiss National Bank lowered its position in shares of Piedmont Office Realty Trust, Inc. (NYSE:PDM) by 7.1% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 235,200 shares of the real estate investment trust’s stock after selling 17,900 shares during the quarter. Swiss National Bank owned about 0.18% of Piedmont Office Realty Trust worth $4,688,000 as of its most recent filing with the SEC.

  • [By Stephan Byrd]

    Headlines about Piedmont Office Realty Trust (NYSE:PDM) have been trending somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Piedmont Office Realty Trust earned a daily sentiment score of 0.16 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 46.9712597210548 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Paul Ausick]

    Piedmont Office Realty Trust Inc. (NYSE: PDM) dropped about 3.5% Tuesday to post a new 52-week low of $17.35. Shares closed at $17.98 on Monday and the stock’s 52-week high is $22.74. Volume was about 60% above the daily average of around 1.3 million shares. The company had no specific news.

Top 10 Performing Stocks For 2019: IRIDEX Corporation(IRIX)

Advisors’ Opinion:

  • [By Max Byerly]

    NxStage Medical (NASDAQ:NXTM) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

  • [By Max Byerly]

    First Light Asset Management LLC reduced its position in shares of IRIDEX Co. (NASDAQ:IRIX) by 48.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 198,581 shares of the medical equipment provider’s stock after selling 189,106 shares during the period. First Light Asset Management LLC owned about 1.70% of IRIDEX worth $1,382,000 at the end of the most recent reporting period.

Top 10 Performing Stocks For 2019: Western Asset Mortgage Capital Corporation(WMC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Lincoln National Corp acquired a new position in Western Asset Mortgage Capital Corp (NYSE:WMC) during the 2nd quarter, Holdings Channel reports. The fund acquired 11,000 shares of the financial services provider’s stock, valued at approximately $115,000.

  • [By Max Byerly]

    ValuEngine lowered shares of Western Asset Mortgage Capit (NYSE:WMC) from a buy rating to a hold rating in a research report report published on Wednesday.

Top 10 Performing Stocks For 2019: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By ]

    As of December 2017, Greenlight Re’s major (10%+) long positions were General Motors (GM), Brighthouse Financial (BHF), gold (GLD), Bayer (OTCPK:BAYZF), and Mylan (MYL). It also holds a long position in Micron (MU), which was the best positive contributor to its portfolio in the first quarter of 2018. These long positions were balanced by shorts in Tesla (TSLA), Netflix (NFLX), and other “bubble basket” stocks. The portfolio is also short Assured Guaranty (AGO), a municipal bond insurer, a position which is hedged by a simultaneous long in Puerto Rican debt. Overall, the portfolio is 93% gross long and 65% gross short. Unlike most insurance portfolios, just 0.5% of investments are in debt instruments and, in fact, Greenlight Re’s short portfolio was 11% allocated to sovereign debt.

  • [By SEEKINGALPHA.COM]

    For the third quarter, the company reported cash and equivalents of $470.4 million, while net income came in at $50 million (includes a gain of $78.7 million from the Immunomedics’ warrant). Without the one-time gain, its loss of $28.7 million would still be an improvement over net loss of $31.8 million for the same quarter last year. For the fourth quarter, the company is guiding for ADCETRIS sales in the range of $82 million to $84 million (total revenue of $128 million to $130 million). In addition to the growing opportunity for ADCETRIS (peak sales in excess of $1 billion) and the intriguing prospects of tucatinib, the company has a promising pipeline of ADC candidates and immuno-oncology assets. Partnered programs with the likes of AbbVie (NYSE:ABBV), Astellas (OTCPK:ALPMY), Genmab (OTCPK:GMXAY), Bayer (OTCPK:BAYZF), Genentech and many more also lend additional credibility to the story.

Top 10 Performing Stocks For 2019: NextEra Energy Partners, LP(NEP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nextera Energy Partners (NEP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nextera Energy Partners (NEP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    IFP Advisors Inc raised its stake in NextEra Energy Partners (NYSE:NEP) by 124.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,558 shares of the solar energy provider’s stock after acquiring an additional 1,416 shares during the quarter. IFP Advisors Inc’s holdings in NextEra Energy Partners were worth $102,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nextera Energy Partners (NEP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on NextEra Energy Partners (NEP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks For 2019: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

  • [By George Budwell]

    Shares of the small-cap biotech Agenus (NASDAQ:AGEN) reversed its year-long down trend by gaining a stately 20.1% last month, according to data from S&P Global Market Intelligence. What sparked this marked turnaround?

  • [By George Budwell]

    Agenus (NASDAQ:AGEN), a small-cap cancer immunotherapy and vaccine company, has started to claw its way back from a steep downturn that began last April. Specifically, the drugmaker’s shares have spiked by a healthy 29% over just the past three trading sessions. 

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech. Agenus Inc. (NASDAQ:AGEN) and Regeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.  

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

Top 10 Performing Stocks For 2019: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Swiss National Bank lowered its position in shares of Snap-on (NYSE:SNA) by 13.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 183,800 shares of the company’s stock after selling 29,700 shares during the quarter. Swiss National Bank owned 0.32% of Snap-on worth $27,118,000 as of its most recent filing with the SEC.

  • [By Garrett Baldwin]

    Earnings season is well underway. And if you’re looking to make real money, the time to get started is now. Money Morning Quantitative Specialist Chris Johnson argues the markets are at a tipping point. And with just a few smart plays in today’s classic stock picker’s market… you can pull in triple-digit gains with just a small investment. Read those picks right here.

    The Top Stock Market Stories for Friday
    General Electric Co. (NYSE: GE) leads the earnings calendar as reporting for the second quarter moves into full swing. The Boston-based conglomerate is expected to report earnings per share (EPS) of $0.18 on top of $29.76 billion in revenue. Former Dallas Federal Reserve Bank Vice President Jerry O’Driscoll offered some choice words for the U.S. central bank. In an interview with CNBC, O’Driscoll warned that the Fed is being “very aggressive” with interest rate policy in 2018. He warned the central bank is ignoring important factors like a rising dollar and the flattening yield curve. The former bank executive argued that he doesn’t see the case for additional rate hikes in the year ahead. This is one reason why investors should protect themselves from any downside caused by the Fed. According to The Wall Street Journal, three top cybersecurity officials are departing their positions at the FBI. The departures are planned due to their ongoing concerns about cybersecurity attacks from abroad and disagreements with the Trump administration.
    Three Stocks to Watch Today: MSFT, SKX, SNA
    Shares of Microsoft Corp. (Nasdaq: MSFT) popped more than 3.2% after the cloud computing and software giant topped earnings expectations after the bell Thursday. The company topped $100 billion for its fiscal 2018. This is the first time that it has ever reached this revenue level for a year. The firm reported EPS of $1.13, topping Wall Street estimates by $0.05. The firm reported revenue of $30.09 billion, besting expectations of $29.21 billion. Shares of Snap-on

  • [By Rich Smith]

    Shares of toolmaker Snap-on (NYSE:SNA) jumped nearly 10% in Thursday trading, closing the day up 9.6% after reporting fiscal Q2 financials that missed analyst expectations for sales, but crushed on earnings.

  • [By Stephan Byrd]

    Bronfman E.L. Rothschild L.P. decreased its position in Snap-on Incorporated (NYSE:SNA) by 62.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 623 shares of the company’s stock after selling 1,051 shares during the quarter. Bronfman E.L. Rothschild L.P.’s holdings in Snap-on were worth $100,000 at the end of the most recent reporting period.

Top 10 Performing Stocks For 2019: Globus Medical, Inc.(GMED)

Advisors’ Opinion:

  • [By Brian Feroldi]

    The excitement makes sense given the opportunity ahead, but growth might prove to be harder to come by in the years ahead. Globus Medical (NYSE:GMED) recently won FDA approval for its Excelsius GPS system, which also assists surgeons with screw placements in the spine and orthopedic surgery procedures.

  • [By Ethan Ryder]

    Northern Trust Corp raised its holdings in shares of Globus Medical Inc (NYSE:GMED) by 2.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,190,383 shares of the medical device company’s stock after acquiring an additional 33,264 shares during the quarter. Northern Trust Corp’s holdings in Globus Medical were worth $60,067,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Schwab Charles Investment Management Inc. raised its stake in shares of Globus Medical Inc (NYSE:GMED) by 8.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 421,775 shares of the medical device company’s stock after purchasing an additional 31,253 shares during the period. Schwab Charles Investment Management Inc. owned 0.44% of Globus Medical worth $21,013,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Globus Medical Inc (NYSE:GMED) – Research analysts at William Blair cut their Q2 2018 earnings per share (EPS) estimates for shares of Globus Medical in a report released on Thursday, May 3rd. William Blair analyst K. Krum now forecasts that the medical device company will earn $0.35 per share for the quarter, down from their previous estimate of $0.37. William Blair also issued estimates for Globus Medical’s Q3 2018 earnings at $0.35 EPS, FY2018 earnings at $1.52 EPS, Q1 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.42 EPS, Q4 2019 earnings at $0.46 EPS and FY2019 earnings at $1.71 EPS.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Globus Medical (GMED)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks For 2019: BLDRS Emerging Markets 50 ADR Index Fund(ADRE)

Advisors’ Opinion:

  • [By Logan Wallace]

    BLDRS Emerging Markets 50 ADR Index (NASDAQ:ADRE) declared a quarterly dividend on Monday, June 18th, Wall Street Journal reports. Investors of record on Tuesday, June 19th will be given a dividend of 0.2285 per share on Tuesday, July 31st. This represents a $0.91 annualized dividend and a yield of 2.15%. The ex-dividend date is Monday, June 18th. This is a positive change from BLDRS Emerging Markets 50 ADR Index’s previous quarterly dividend of $0.00851.

Top 10 Performing Stocks For 2019: Check Point Software Technologies Ltd.(CHKP)

Advisors’ Opinion:

  • [By Chris Lange]

    Check Point Software Technologies Ltd.’s (NASDAQ: CHKP) short interest decreased to 8.45 million shares from the previous 9.69 million. Shares were trading at $113.57, in a 52-week range of $93.76 to $120.81.

  • [By Nicholas Rossolillo]

    Shares of cybersecurity outfit Check Point Software Technologies (NASDAQ:CHKP) have been underperforming for the past year. As cyberattacks have gained notoriety, lots of competition has cropped up and taken a bite out of the company’s market share. Even with an attractive valuation, it may not be time yet for investors to double down on Check Point as the business gets serious about marketing new security tools.

  • [By Chris Lange]

    Check Point Software Technologies Ltd.’s (NASDAQ: CHKP) short interest increased to 11.56 million shares from the previous reading of 10.59 million. Shares were trading at $97.55, in a 52-week range of $93.76 to $119.20.

Top Clean Energy Stocks To Own For 2019

It’s important for investors to know how to invest in penny stocks safely. That’s because they’re often volatile and can sometimes be fraudulent, despite offering triple-digit returns in a matter of weeks. We’ll show you our top two strategies for finding good penny stocks to buy, plus our small-cap stock pick primed for double-digit growth this year…

Video3 Strategies for Investing in Penny Stocks

If you’re looking for proof of just how explosively profitable penny stocks are, Delcath Systems Inc. (Nasdaq: DCTH) is a perfect piece of evidence. This company saw its stock price surge from $0.02 on June 1 to $0.19 on June 26. That marked a stunning 850% gain, which happened after the company announced phase 2 trial data for its cancer drug Melphalan would be released.

But these triple-digit returns aren’t always justified by the company’s profits or business potential. For instance, Chinese energy company Hongli Clean Energy Technologies Corp. (Nasdaq: CETC) saw shares jump 144% from $1.90 to $4.63 during just the first five sessions of April.

Top Clean Energy Stocks To Own For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Spencer Israel]

    The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy. The blue line represents a predictive moving average that shows what’s going to happen three days in advance, and the black line is a simple 10-day moving average. A crossover of the blue line over the black line indicates a bullish signal from the software, and vice versa for a bearish signal.

    iAthus Capital Holdings, Inc. (OTC: ITHUF)

    Up 94 percent YTD

  • [By Javier Hasse]

    Licensed cannabis production facilities owner and operator iAnthus Capital Holdings Inc (OTC: ITHUF) announced a $50 million investment from Gotham Green Partners. Management believes this is the largest investment to date by a single investor in a publicly traded U.S. cannabis operating company. iAnthus plans to allocate the proceeds of this financing to repay a $20 million one-year note and accrued interest to VCP Bridge LLC; continue to build out cultivation facilities and dispensaries in the New York and Florida markets; and, potentially, to expand activities. The remaining expenditures for completing iAnthus’ Massachusetts and Vermont operations will be funded with current cash on hand, management assured.

  • [By ]

    Much of the focus of cannabis investors has been centered on Canada and California. This makes sense given that they are the two largest recreational (or soon to be) cannabis markets in the world. However, one publicly traded company with US-centric cannabis operations has taken a different approach. iAnthus Capital is listed in Canada on the CSE (OTCQB:ITHUF), but is headquartered in New York and incorporated in Delaware. Unlike other Canadian-listed cannabis companies, most of which are aiming to get in on the highly competitive green-rush in California and Canada, iAnthus has set its sights on becoming the dominant player on the U.S. East Coast.

Top Clean Energy Stocks To Own For 2019: Magic Software Enterprises Ltd.(MGIC)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine lowered shares of Magic Software Enterprises (NASDAQ:MGIC) from a buy rating to a hold rating in a report issued on Monday.

    Several other equities research analysts have also recently issued reports on MGIC. Zacks Investment Research raised shares of Magic Software Enterprises from a sell rating to a hold rating in a research report on Wednesday, January 17th. BidaskClub cut shares of Magic Software Enterprises from a sell rating to a strong sell rating in a research report on Tuesday, January 23rd. Finally, HC Wainwright set a $10.00 target price on shares of Magic Software Enterprises and gave the stock a buy rating in a research report on Thursday, March 1st. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has an average rating of Hold and an average target price of $9.81.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Magic Software Enterprises (MGIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Magic Software Enterprises Ltd. (NASDAQ: MGIC) is estimated to report quarterly earnings at $0.14 per share on revenue of $67.07 million.

    Canadian Solar Inc. (NASDAQ: CSIQ) is projected to report quarterly earnings at $0.47 per share on revenue of $1.34 billion.

  • [By Logan Wallace]

    HC Wainwright set a $10.00 target price on Magic Software Enterprises (NASDAQ:MGIC) in a research note released on Thursday morning. The firm currently has a buy rating on the software maker’s stock.

Top Clean Energy Stocks To Own For 2019: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

Top 10 High Tech Stocks To Own Right Now

GARP is short for “growth at a reasonable price.” Different investors have different definitions for what is and isn’t a GARP stock. I have my own definition, and Alphabet Inc (NASDAQ:GOOGL, NASDAQ:GOOG) fits it, and rather nicely I might add.

I consider a stock to be a growth stock if it is growing earnings at a rate of 15% or higher from one year to the next, ideally over a five-year annualized time frame. Also, I consider a reasonable price for a non-growth stock to be anything trading with a PEG ratio of 1.0 or less. If a stock, any stock, trades at a PEG ratio of 1.0 or less, I consider it to be a value stock.

Thus, if I am able to find a growth stock that trades at a PEG ratio of 1.0 or less, it is essentially the value version of a growth stock, or a GARP stock. These stocks are few and far between. But if you can find them, you’re getting a terrific value.

There are also other considerations in terms of valuation. I subtract the company’s net cash position from its market cap to determine its P/E ratio. I also permit a 10% premium to earnings growth expectations for each of the following: excessive net cash position, exceptional free cash flow and world-class brand name.

Top 10 High Tech Stocks To Own Right Now: Forrester Research, Inc.(FORR)

Advisors’ Opinion:

  • [By Alexander Bird]

    According to a report from Forrester Research Inc. (Nasdaq: FORR), online sales will account for 17% of all retail sales in the United States by 2022.

Top 10 High Tech Stocks To Own Right Now: ImmuCell Corporation(ICCC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.

Top 10 High Tech Stocks To Own Right Now: The NASDAQ OMX Group Inc.(NDAQ)

Advisors’ Opinion:

  • [By Sean Williams]

    However, Canada becoming the first developed country in the world to legalize adult-use cannabis is far from the only “marijuana first” we’ve witnessed this year. In February, Canadian weed investment company Cronos Group (NASDAQ:CRON), which has three core assets, announced that it was becoming the first Canadian pot stock to uplist to the Nasdaq (NASDAQ:NDAQ). Moving from the over-the-counter (OTC) exchange to a more reputable exchange like the Nasdaq allowed for improved liquidity, as well as cleared the way for institutional investors to take a position in Cronos Group. Wall Street traditionally shies away from investing in OTC-listed companies.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Asit Sharma]

    In its last sequential quarter, Nasdaq Inc.(NASDAQ:NDAQ)relied on non-trading segments for growth as its market-services segment turned in a near flat performance. In the first quarter of 2018, however, healthy trading volumes resumed, and Nasdaq achieved expansion in each of its four operating segments. Before sifting through important highlights for the quarter, let’s briefly review the top-level performance:

  • [By Ethan Ryder]

    Shares of Nasdaq Inc (NASDAQ:NDAQ) have been given an average rating of “Hold” by the fifteen analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation, six have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $87.54.

  • [By Wayne Duggan]

    Nasdaq Inc (NASDAQ: NDAQ) CEO Adena Friedman told CNBC the company is open to the possibility of adding a cryptocurrency exchange over time. Nasdaq also announced a deal to allow cryptocurrency exchange Gemini access to Nasdaq’s surveillance technology. Friedman told CNBC that cryptocurrency regulations must first be ironed out before the Nasdaq would add a crypto exchange.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nasdaq (NDAQ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Own Right Now: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Paul Ausick]

    While the transition period from one chief executive officer to another has barely gotten started at Volkswagen, some big changes may already be afoot. VW’s commercial-vehicles unit, Volkswagen Truck & Bus, is looking at the possibility of buying more shares in U.S. truck maker Navistar International Corp. (NYSE: NAV) or even acquiring the whole company outright.

  • [By Ethan Ryder]

    NavCoin (CURRENCY:NAV) traded up 3.1% against the US dollar during the 24 hour period ending at 12:00 PM ET on May 14th. NavCoin has a market cap of $69.58 million and approximately $924,266.00 worth of NavCoin was traded on exchanges in the last day. Over the last week, NavCoin has traded 12.8% lower against the US dollar. One NavCoin coin can now be bought for $1.11 or 0.00012616 BTC on cryptocurrency exchanges including LiteBit.eu, Upbit, cfinex and Poloniex.

  • [By Shane Hupp]

    NavCoin (CURRENCY:NAV) traded up 17.9% against the dollar during the 1-day period ending at 15:00 PM E.T. on May 20th. Over the last week, NavCoin has traded up 19.5% against the dollar. One NavCoin coin can currently be bought for about $1.28 or 0.00015092 BTC on exchanges including Cryptopia, Binance, Bittrex and cfinex. NavCoin has a total market capitalization of $80.73 million and $13.02 million worth of NavCoin was traded on exchanges in the last day.

Top 10 High Tech Stocks To Own Right Now: Invesco Pennsylvania Value Municipal Income Trust(VPV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News stories about Invesco Pennsylvania Value Mncpl Incm Tr (NYSE:VPV) have been trending very positive recently, Accern reports. The research group scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Invesco Pennsylvania Value Mncpl Incm Tr earned a news impact score of 0.65 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 48.6094961265878 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Top 10 High Tech Stocks To Own Right Now: Unit Corporation(UNT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Unit (UNT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Own Right Now: Del Taco Restaurants, Inc.(TACO)

Advisors’ Opinion:

  • [By Max Byerly]

    Del Taco Restaurants Inc (NASDAQ:TACO) Director Patrick Walsh acquired 10,000 shares of the business’s stock in a transaction on Friday, May 18th. The stock was acquired at an average price of $11.43 per share, with a total value of $114,300.00. Following the transaction, the director now owns 31,866 shares in the company, valued at approximately $364,228.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

  • [By ]

    Del Taco Restaurants (TACO) : “We have so many others in that group, why go with this one?”

    Snap (SNAP) : “I think this one is going nowhere.”

Top 10 High Tech Stocks To Own Right Now: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

Top 10 High Tech Stocks To Own Right Now: MSA Safety Incorporporated(MSA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Mine Safety Appliances (NYSE:MSA) have been given an average rating of “Hold” by the six research firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $97.33.

  • [By Shane Hupp]

    Mine Safety Appliances (NYSE: MSA) is one of 26 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Mine Safety Appliances to similar companies based on the strength of its risk, earnings, institutional ownership, valuation, dividends, analyst recommendations and profitability.

Top 10 High Tech Stocks To Own Right Now: Leggett & Platt, Incorporated(LEG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Leggett & Platt (NYSE: LEG) and Hooker Furniture (NASDAQ:HOFT) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Leggett & Platt (LEG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

best stock for investment

U.S. tech stocks recently had their largest inflows in 38 weeks, as I wrote on Tuesday.   To me, that's a sign that my "Melt Up" thesis is in full swing – that investors finally love stocks. We could see incredible gains over the next 12 to 18 months… And you want to be in on it.   However, for maximum returns on my long-term investments – the ones I'll be holding long after the Melt Up – I don't want to buy what's loved. I want to buy what's "hated."   To find the bottom, I don't want to see record inflows from investors. I want to see record outflows.   Record outflows are a great sign to me that an investment is hated. Then I want to wait for the start of an uptrend. That's my basic recipe for finding a great long-term investment…   Last week – the same week that U.S. tech-stock funds attracted more than a billion dollars – Reuters reported some crazy news about Japanese stock flows.

best stock for investment: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

best stock for investment: The Descartes Systems Group Inc.(DSGX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Thursday.

best stock for investment: Ormat Technologies, Inc.(ORA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ormat Technologies (ORA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

best stock for investment: Nomura Holdings Inc ADR(NMR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Nomura Holdings Inc. (NYSE: NMR) is a Japanese financial services company that provides a variety of financial services to corporations, governments, institutions, and individuals around the world.

best stock for investment: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies within the Government Services and Hydrocarbon sectors.”

best stock for investment: Premier, Inc.(PINC)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Premier (PINC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

best penny stocks

While all your friends are posting on Facebook about what they plan to do with their tax returns, you’re scrambling to figure out how you’e going to drum up the money you owe in taxes.

Payingtaxescan be a bummer, especially if you are short on cash or unprepared. Here’s what you can do to plan accordinglyfor next year.

Make sure you are withholding the correct amountfrom your W-4

Check yourW-4 form or your withholding exemption form to make sure you are withholding the correct amount,according to Paul F. McGee, CPA and professor in the Accounting and Finance Department at Salem State University.

While the form may look like another language, you don’t need to worry about reading it too closely, just make sure you are withholding 0 instead of 1 or another number, according to McGee.

best penny stocks: Apollo Investment Corporation(AINV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Apollo Investment (NASDAQ:AINV) will be posting its quarterly earnings results before the market opens on Friday, May 18th. Analysts expect Apollo Investment to post earnings of $0.16 per share for the quarter.

  • [By Lisa Levin] Gainers
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday.
    China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday.
    Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results.
    Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results.
    Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid.
    Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results.
    Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings.
    Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results.
    Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday.
    Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings.
    HMS Holdings Corp (NASDAQ: H

best penny stocks: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

best penny stocks: News Corporation(NWS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

best penny stocks: Approach Resources Inc.(AREX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

best penny stocks: Era Group, Inc.(ERA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Era Group (NYSE:ERA) shares hit a new 52-week high and low during trading on Thursday . The stock traded as low as $12.57 and last traded at $12.57, with a volume of 1356 shares. The stock had previously closed at $12.12.

  • [By Logan Wallace]

    ERA (CURRENCY:ERA) traded up 1.2% against the U.S. dollar during the 24-hour period ending at 20:00 PM Eastern on May 8th. During the last week, ERA has traded 4.3% lower against the U.S. dollar. ERA has a total market cap of $0.00 and $1,610.00 worth of ERA was traded on exchanges in the last day. One ERA coin can currently be bought for approximately $0.0549 or 0.00000600 BTC on cryptocurrency exchanges including CoinExchange and Cryptohub.

best penny stocks: PICO Holdings Inc.(PICO)

Advisors’ Opinion:

  • [By Shane Hupp]

    PICO (NASDAQ: PICO) and Urban Edge Properties (NYSE:UE) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Top Value Stocks To Own Right Now

Texas Yale Capital Corp. reduced its stake in shares of Enbridge (NYSE:ENB) (TSE:ENB) by 7.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,681 shares of the pipeline company’s stock after selling 3,739 shares during the quarter. Texas Yale Capital Corp.’s holdings in Enbridge were worth $1,469,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Meag Munich Ergo Kapitalanlagegesellschaft MBH raised its stake in Enbridge by 3.6% in the fourth quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 305,430 shares of the pipeline company’s stock valued at $12,033,000 after buying an additional 10,519 shares during the last quarter. DAVENPORT & Co LLC raised its stake in Enbridge by 38.2% in the fourth quarter. DAVENPORT & Co LLC now owns 1,321,105 shares of the pipeline company’s stock valued at $51,668,000 after buying an additional 365,415 shares during the last quarter. Capital City Trust Co. FL raised its stake in Enbridge by 19.9% in the fourth quarter. Capital City Trust Co. FL now owns 22,936 shares of the pipeline company’s stock valued at $959,000 after buying an additional 3,804 shares during the last quarter. BNP Paribas Arbitrage SA raised its stake in Enbridge by 593.2% in the fourth quarter. BNP Paribas Arbitrage SA now owns 817,195 shares of the pipeline company’s stock valued at $32,137,000 after buying an additional 699,313 shares during the last quarter. Finally, QS Investors LLC raised its stake in Enbridge by 58.4% in the fourth quarter. QS Investors LLC now owns 15,462 shares of the pipeline company’s stock valued at $605,000 after buying an additional 5,701 shares during the last quarter. Hedge funds and other institutional investors own 62.87% of the company’s stock.

Top Value Stocks To Own Right Now: DHI Group, Inc.(DHX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    DHI Group, Inc. (NYSE:DHX) – Analysts at B. Riley lifted their Q2 2018 earnings per share estimates for DHI Group in a research report issued to clients and investors on Wednesday, May 9th. B. Riley analyst K. Anderson now forecasts that the technology company will post earnings of $0.05 per share for the quarter, up from their prior estimate of $0.04. B. Riley currently has a “Hold” rating and a $2.00 target price on the stock. B. Riley also issued estimates for DHI Group’s Q4 2018 earnings at $0.07 EPS and FY2019 earnings at $0.15 EPS.

Top Value Stocks To Own Right Now: UNITIL Corporation(UTL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Pacific Gas and Electric (NYSE: PCG) and Unitil (NYSE:UTL) are both utilities companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Top Value Stocks To Own Right Now: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

best securities to invest in

"I remember when the Dow hit 1,000, and then 2,000," a friend in his 70s told me last month at lunch…   "Now the Dow's near 20,000. That's scary."   This friend is no dummy… He founded a major corporation that traded on the stock market. He had tens of thousands of employees. His net worth hit nine figures.   And he's scared. I get that… We're in uncharted territory. But I have a positive message today:   Stocks can go much higher this year. And there are two major reasons why.   Let me explain them both…   First, fearing new highs simply doesn't make sense. But I do understand why it happens.   If prices hit a new all-time high, then they only have two potential places to go… somewhere they've already been, or somewhere they've never been.

best securities to invest in: Select Medical Holdings Corporation(SEM)

Advisors’ Opinion:

  • [By ]

    Select Medical Holdings (SEM) : “I’d go with the best and that’s HCA Holdings (HCA) .”

    Cramer and the AAP team say Citigroup (C) shows steady progress in first-quarter earnings report. Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By ]

    Cramer was bearish on Oclaro (OCLR) , Stratasys (SSYS) , Washington Prime Group (WPG) and Select Medical Holdings (SEM) .

    No-Huddle Offense 

    In his “No-Huddle Offense” segment, Cramer proclaimed that it’s a fallacy to think that a low price/earnings multiple always means a stock is too cheap. Sometimes, the earnings estimates are simply too high.

best securities to invest in: Ducommun Incorporated(DCO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Astronics (NASDAQ: ATRO) and Ducommun (NYSE:DCO) are both small-cap aerospace companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    NVIDIA Corporation (NASDAQ: NVDA) is estimated to post quarterly earnings at $1.45 per share on revenue of $2.89 billion.
    News Corporation (NASDAQ: NWSA) is projected to post quarterly earnings at $0.07 per share on revenue of $1.99 billion.
    Symantec Corporation (NASDAQ: SYMC) is estimated to post quarterly earnings at $0.39 per share on revenue of $1.19 billion.
    Pilgrim's Pride Corporation (NASDAQ: PPC) is projected to post quarterly earnings at $0.54 per share on revenue of $2.65 billion.
    Hawaiian Electric Industries, Inc. (NYSE: HE) is expected to post quarterly earnings at $0.38 per share on revenue of $556.81 million.
    Air Lease Corporation (NYSE: AL) is estimated to post quarterly earnings at $1.01 per share on revenue of $383.37 million.
    Flowserve Corporation (NYSE: FLS) is expected to post quarterly earnings at $0.27 per share on revenue of $880.89 million.
    Civitas Solutions, Inc. (NYSE: CIVI) is projected to post quarterly earnings at $0.12 per share on revenue of $396.25 million.
    The Trade Desk, Inc. (NASDAQ: TTD) is estimated to post quarterly earnings at $0.1 per share on revenue of $73.23 million.
    Amdocs Limited (NYSE: DOX) is projected to post quarterly earnings at $0.95 per share on revenue of $980.50 million.
    Yelp Inc. (NYSE: YELP) is estimated to post quarterly loss at $0.04 per share on revenue of $220.14 million.
    Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) is expected to post quarterly earnings at $0.43 per share on revenue of $210.01 million.
    TiVo Corporation (NASDAQ: TIVO) is projected to post quarterly earnings at $0.37 per share on revenue of $198.62 million.
    Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) is expected to post quarterly earnings at $0.17 per share on revenue of $153.87 million.
    Uniti Group Inc. (NASDAQ: UNIT) is estimated to post quarterly earnings at $0.01 per share on revenue of $247.16 million.
    Jagged Peak En

best securities to invest in: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

best securities to invest in: Zynga Inc.(ZNGA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Zynga (ZNGA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Zynga (NASDAQ: ZNGA) is one of 61 publicly-traded companies in the “Data processing & preparation” industry, but how does it weigh in compared to its rivals? We will compare Zynga to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, institutional ownership, risk and profitability.

best securities to invest in: Sorrento Therapeutics, Inc.(SRNE)

Advisors’ Opinion:

  • [By William Romov]

    San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

    On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”

  • [By ]

    Sorrento Therapeutics (SRNE) : “This is the kind of speculative stock that I like.”

    Geron (GERN) : “Let’s stick with high quality like Thermo Fisher Scientific (TMO) .”

  • [By ]

    In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .

Best Medical Stocks To Own For 2018

Bethesda, MD, based Investment company Absolute Investment Management Llc buys iShares Core S&P 500, iShares Core U.S. Aggregate Bond, Schwab US Aggregate Bond, United Parcel Service Inc, United States Natural Gas Fund LP, iShares Russell Mid-Cap, iShares Core S&P Mid-Cap, iShares Core S&P Small-Cap, Snap Inc, Schwab U.S. Large-Cap, sells SPDR Select Sector Fund – Health Care, ProShares Short MSCI Emerging Markets, Medical Properties Trust Inc, Vanguard FTSEEuropean, Putnam Managed Municipal Income Trust during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Absolute Investment Management Llc. As of 2017-03-31, Absolute Investment Management Llc owns 105 stocks with a total value of $14 million. These are the details of the buys and sells.

New Purchases: IVV, UNG, IJH, IWO, IWS, SCHX, SNAP, ZIXI, Added Positions: NOBL, SPY, MINT, AGG, SCHZ, UPS, IWR, IJR, GNE, AMLP, Reduced Positions: XLV, EUM, MPW, VGK, PMM, CCI, OHI, XLE, NZF, GLD, Sold Out: VNQ, KRE, AMT, DD, CUBI, KO, V, CERS, INO,

For the details of ABSOLUTE INVESTMENT MANAGEMENT LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=ABSOLUTE+INVESTMENT+MANAGEMENT+LLC

Best Medical Stocks To Own For 2018: Wausau Paper Corp.(WPP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares rose 29.5 percent to $2.15 in pre-market trading after reporting pre-clinical data demonstrating potential of Prexigebersen presented at the annual American Association for Cancer Research meeting in Chicago.
    Sientra, Inc. (NASDAQ: SIEN) rose 16.7 percent to $12.90 in pre-market trading following the announcement of FDA approval for PMA supplement.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 13.5 percent to $2.95 in pre-market trading after climbing 14.04 percent on Wednesday.
    Harmony Gold Mining Company Limited (NYSE: HMY) rose 5.6 percent to $2.09 in pre-market trading.
    Alcoa Corporation (NYSE: AA) shares rose 5 percent to $62.32 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its FY18 adjusted EBITDA outlook.
    Gold Fields Limited (ADR) (NYSE: GFI) shares rose 4.9 percent to $4.11 in pre-market trading after gaining 1.03 percent on Wednesday.
    ABB Ltd (NYSE: ABB) shares rose 4.3 percent to $24.47 in pre-market trading after reporting Q1 results.
    WPP plc (NYSE: WPP) rose 4.2 percent to $82.99 in pre-market trading.
    American Express Company (NYSE: AXP) rose 4 percent to $98.95 in pre-market trading after the company reported stronger-than-expected profit for its first quarter.
    HSBC Holdings plc (NYSE: HSEA) rose 3.4 percent to $27.30 in pre-market trading.
    Shire plc (NASDAQ: SHPG) rose 3.4 percent to $167.95 in pre-market trading. Takada offered to buy Shire at £46.50 per share, Reuters reported.
    Vipshop Holdings Limited (NYSE: VIPS) rose 3.1 percent to $16.43 in pre-market trading.
    iRobot Corporation (NASDAQ: IRBT) shares rose 3 percent to $63.66 in the pre-market trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By ]

    Embattled WPP Group (WPP) CEO Martin Sorrell, no stranger to business news channels and fat annual compensation checks, has quit as CEO. Below is a statement from Sorrell obtained by TheStreet.

Best Medical Stocks To Own For 2018: Capitol Federal Financial(CFFN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BankUnited (NYSE: BKU) and Capitol Federal Financial (NASDAQ:CFFN) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Best Medical Stocks To Own For 2018: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Shares of Agenus Inc (NASDAQ:AGEN), a biopharmaceutical company developing cancer therapies, had fallen about 14.5% as of 3:20 p.m. EST on Wednesday. Investors weren’t too thrilled about its cancer vaccine’s recent clinical trial failure.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

  • [By Lisa Levin]

    Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

    Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

Best Medical Stocks To Own For 2018: Saratoga Investment Corp(SAR)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine downgraded shares of Saratoga Investment (NYSE:SAR) from a buy rating to a hold rating in a research report released on Wednesday.

    A number of other analysts have also issued reports on the stock. National Securities reiterated a neutral rating and set a $24.00 price target (up from $23.00) on shares of Saratoga Investment in a research note on Friday, January 12th. Zacks Investment Research lowered shares of Saratoga Investment from a hold rating to a sell rating in a research note on Friday, March 2nd. Finally, B. Riley initiated coverage on shares of Saratoga Investment in a research note on Tuesday, March 27th. They set a buy rating and a $23.50 price target on the stock. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Saratoga Investment presently has a consensus rating of Buy and an average price target of $24.38.

Best Medical Stocks To Own For 2018: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Nelson Hem]

    Medical products maker Halyard Health Inc (NYSE: HYH) stumbled after its spinoff from paper products giant Kimberly Clark Corp (NYSE: KMB), according to “Halyard Health Shares Look Poised to Double” by David Englander. See why Barron’s thinks its shares could double as this Georgia-based company pursues acquisitions and expands its product lineup.

  • [By Logan Wallace]

    Renaissance Technologies LLC acquired a new position in Halyard Health (NYSE:HYH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9,805 shares of the medical instruments supplier’s stock, valued at approximately $453,000.

  • [By Nelson Hem]

    See what Barron’s feels are the prospects for Ingersoll-Rand PLC (NYSE: IR) despite the woes in energy, Michael Kors Holdings Ltd (NYSE: KORS) with its new products and international expansion, the Valvoline spinoff from Ashland Inc (NYSE: ASH), as well as Halyard Health Inc (NYSE: HYH) as it pursues acquisitions and expands its product lineup.